These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9885106)

  • 1. Treatment of advanced heart failure in a young man with familial cardiomyopathy.
    Massin EK
    Tex Heart Inst J; 1998; 25(4):294-7. PubMed ID: 9885106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electromechanical associations.
    Rogers JG; Cain ME
    N Engl J Med; 2004 May; 350(21):2193-5. PubMed ID: 15152065
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
    Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH;
    N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience of weaning from left ventricular assist system in an acutely-ill patient with dilated cardiomyopathy and severe left ventricular dysfunction: a case report].
    Fujimura M; Komamura K; Sasaki T; Nakatani S; Yasumura Y; Yamagishi M; Miyatake K; Tsukada T; Sasako Y; Nakatani T
    J Cardiol; 1998 Jan; 31(1):31-6. PubMed ID: 9488949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CME ECG 33. Pacemaker rhythm or no pacemaker rhythm. Sinus rhythm with mainly normal conduction].
    Steffel J; Brunckhorst C
    Praxis (Bern 1994); 2011 Apr; 100(9):564-5. PubMed ID: 21526479
    [No Abstract]   [Full Text] [Related]  

  • 8. Contemporary Outcome in Patients With Idiopathic Dilated Cardiomyopathy.
    Broch K; Murbræch K; Andreassen AK; Hopp E; Aakhus S; Gullestad L
    Am J Cardiol; 2015 Sep; 116(6):952-9. PubMed ID: 26233575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.
    McNally EM; Kaltman JR; Benson DW; Canter CE; Cripe LH; Duan D; Finder JD; Groh WJ; Hoffman EP; Judge DP; Kertesz N; Kinnett K; Kirsch R; Metzger JM; Pearson GD; Rafael-Fortney JA; Raman SV; Spurney CF; Targum SL; Wagner KR; Markham LW; ;
    Circulation; 2015 May; 131(18):1590-8. PubMed ID: 25940966
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological therapy of arrhythmias complicating dilated cardiomyopathy--implications of the arrhythmogenic substrate.
    Gumbrielle T; Campbell RW
    Eur Heart J; 1993 Sep; 14 Suppl E():103-6. PubMed ID: 8223746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide as a marker of heart failure in children with left ventricular volume overload.
    Kotby AA; Taman KH; Sedky HT; Habeeb NM; El-Hadidi ES; Yosseif HS
    J Paediatr Child Health; 2013 Jan; 49(1):43-7. PubMed ID: 23279037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy and course of dilated cardiomyopathy].
    Hess OM; Greminger P; Maire R; Turina J; Krayenbühl HP
    Schweiz Med Wochenschr; 1985 May; 115(20):693-7. PubMed ID: 3892658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction.
    Bertini M; Ziacchi M; Biffi M; Biagini E; Rocchi G; Martignani C; Ferlito M; Pasquale F; Cervi E; Branzi A; Rapezzi C; Boriani G
    Heart; 2011 Feb; 97(4):295-300. PubMed ID: 21163889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
    Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
    Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
    Plante E; Gaudreau M; Lachance D; Drolet MC; Roussel E; Gauthier C; Lapointe E; Arsenault M; Couet J
    Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catastrophic massive intracardiac thrombus in a 40-year-old patient with dilated cardiomyopathy.
    Jeon GJ; Song BG; Kim TH; Yang HJ; Ma BO; Park YH; Kang GH; Chun WJ; Oh JH
    Nepal Med Coll J; 2011 Sep; 13(3):226-8. PubMed ID: 22808822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.
    Pankuweit S; Lüers C; Richter A; Ruppert V; Gelbrich G; Maisch B;
    Eur J Clin Invest; 2015 Sep; 45(9):906-17. PubMed ID: 26094644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.